Ghisallo Capital Management »

Intra Cellular Therapies shares owned by Ghisallo Capital Management

Quarter-by-quarter ownership of Intra Cellular Therapies (ITCI) shares owned by Ghisallo Capital Management from 13F filings

Historical chart of Ghisallo Capital Management investment in Intra Cellular Therapies

Tip: Access up to 7 years of quarterly data

All positions including Intra Cellular Therapies held by Ghisallo Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Intra Cellular Therapies by Ghisallo Capital Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $3.4M 50k 68.49

More positions owned by Ghisallo Capital Management

Diamondback Energy (FANG)
Dell Technologies CL C (DELL)
Ge Healthcare Technologies I Common Stock (GEHC)
Pinga 0.875 07/22/29 Convertible Bond (PIAIF)
Trip Com Group Ads (TCOM)
Lineage (LINE)
Viking Holdings Ord Shs (VIK)
Baba 0.500 06/01/31 Cvt Put Convertible Bond (Principal)
Hawaiian Electric Industries (HE)
Ul Solutions Class A Com Shs (ULS)
Palantir Technologies Cl A (PLTR)
Nasdaq Omx (NDAQ)
Pacs Group Com Shs (PACS)
Corebridge Finl (CRBG)
Posco Holdings Sponsored Adr (PKX)

View all positions for Ghisallo Capital Management

Top funds holding Intra Cellular Therapies

FMR
Vanguard Group
BlackRock
Jpmorgan Chase & Co
Daniel D. Thurber
Norges Bank Investment Management
Invesco
venBio Select Advisor
Bellevue Group
State Street Corporation
Franklin Resources
Geode Capital Management
ClearBridge Advisors
Pictet Asset Management Holding SA
Deep Track Capital

View all funds holding Intra Cellular Therapies